Status:
COMPLETED
KRAS Mutation and Incidence of the Colorectal Carcinoma in Martinique Between 2007 and 2009
Lead Sponsor:
University Hospital Center of Martinique
Conditions:
Colorectal Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
* There is no data at present concerning the KRAS mutation in patients from Martinique with colorectal cancer. Despite the fact that the incidence of this disease continues to increase there is no rec...
Detailed Description
* The colorectal carcinogenesis is complex. It influences among others, the EGFR (Epidermal Growth Factor Receptor) which activation leads to tumoral proliferation, differentiation and invasion. The b...
Eligibility Criteria
Inclusion
- for the study of the KRAS mutation: 250 patients drawn by lots among the cases of colorectal carcinoma diagnosed between January 1st, 2007 and December 31st, 2009 in Martinique
- for the study of incidence: patient for whom was diagnosed a colorectal carcinoma between January 1st, 2007 and December 31st, 2009
- patient unopposed and in free agreement to participate in this study
- patient having his main home in Martinique at the time of the diagnosis
- patient 18 years old and over
Exclusion
- patient whose diagnosis is prior to 2007 and later in 2009
- patient having shown opposition to the participation in this study
- patient minor or under guardianship
- patient not having his main home in Martinique at the time of the diagnosis
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2011
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT01151007
Start Date
July 1 2011
End Date
December 1 2011
Last Update
September 23 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Laboratoire de Virologie - CHU de Fort de France
Fort de France, Martinique, France, 97261